S. Cokmert Et Al. , "Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer," JOURNAL OF BUON , vol.19, no.1, pp.75-82, 2014
Cokmert, S. Et Al. 2014. Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer. JOURNAL OF BUON , vol.19, no.1 , 75-82.
Cokmert, S., Demir, L., Can, A., Akyol, M., Bayoglu, I. V., Dirican, A., ... Kucukzeybek, Y.(2014). Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer. JOURNAL OF BUON , vol.19, no.1, 75-82.
Cokmert, Suna Et Al. "Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer," JOURNAL OF BUON , vol.19, no.1, 75-82, 2014
Cokmert, Suna Et Al. "Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer." JOURNAL OF BUON , vol.19, no.1, pp.75-82, 2014
Cokmert, S. Et Al. (2014) . "Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer." JOURNAL OF BUON , vol.19, no.1, pp.75-82.
@article{article, author={Suna Cokmert Et Al. }, title={Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer}, journal={JOURNAL OF BUON}, year=2014, pages={75-82} }